In this jam-packed episode, Mitch Robbins sits down with Dr. Greg Critchfield, a titan in molecular diagnostics and biotech. This is a leader who’s done it all—from spearheading Myriad Genetics into global prominence to raising over $300 million for groundbreaking women’s health innovations. But that’s just scratching the surface!

🔬 Why You Need to Tune In: Dr. Critchfield shares how his early passion for diagnostics was sparked by his father, a physician, who once said: “The hardest part is the diagnosis.” Since then, Greg has led pioneering efforts in genomics, transforming the landscape of molecular diagnostics and helping shape the future of personalized medicine.

🌟 The Ultimate CEO Insights: What does it take to build powerhouse teams? How do you scale a company from a biotech hopeful to a market leader with 54% annual growth for 12 years? Dr. Critchfield shares priceless advice on surrounding yourself with relentless problem solvers and the importance of challenging the status quo. His Formula 1 analogy on biotech performance sums it all up.

💡 Challenges and Triumphs: Taking a company public? Greg did it virtually during the pandemic and shares the inside scoop on how they pulled off a successful IPO without a single in-person meeting. Plus, hear about the toughest decisions he’s made as a CEO—when loyalty to long-serving employees meets the harsh realities of growth.

🌊 Bonus: Passionate about the environment? Greg’s work with Bear Lake Watch will inspire you to think about conservation in a whole new way.

This episode is a masterclass in leadership, biotech innovation, and building lasting impact—don’t miss it!

🎙️ Hit play now to dive into a world where diagnosis meets data and biotech pushes the boundaries of what’s possible.